Ultrahuman has announced the launch of M2 Live, its second-generation continuous glucose monitoring platform designed for the US market. This device represents a major step in democratizing metabolic monitoring, making it accessible not only to diabetics but also to anyone interested in tracking their health. The key innovation lies in using Abbott's Lingo sensors, which are available over the counter without a prescription at a lower cost compared to previous models.
The previous M1 Live system used Abbott's Freestyle Libre sensors, which required a prescription in the US and were more expensive than in other regions. With M2 Live, Ultrahuman leverages the Lingo sensors, which can be purchased freely. This change opens the door to a wider audience, including the growing number of non-diabetics who use CGMs to optimize their diet and overall wellness.
Sponsored Protocol
M2 Live works by integrating glucose data from the Abbott sensor with data collected by Ultrahuman's smart ring. The Ultrahuman app combines these data streams to provide a comprehensive metabolic picture. The proprietary artificial intelligence, named Jade, analyzes the data and returns a personalized metabolic score, offering guidance on how to improve glucose management based on sleep, stress, and physical activity.
Pricing is competitive: a single sensor lasts 14 days and costs $129, while a monthly subscription is available for $99 per month. Availability in the US is expected in the coming weeks. This pricing strategy could accelerate the mass adoption of CGMs, already growing among athletes and fitness enthusiasts.
The launch of M2 Live fits into a broader trend of interest in metabolic health, also seen in innovations like Midjourney's full-body ultrasonic scanner, which promises complete analysis in 60 seconds. According to industry experts, the future of health increasingly relies on personalized data and wearable devices. For more information, refer to the Wikipedia page on continuous glucose monitoring.
Sponsored Protocol
In summary, Ultrahuman M2 Live simplifies and lowers the cost of glucose monitoring, making it accessible to a broader audience. With Jade AI and synergy with Abbott sensors, it provides concrete tools to improve metabolic awareness. It remains to be seen how the market will react and whether competitors will follow the same path.
